Cite
Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β‑catenin signaling pathway.
MLA
Li, Kaizhi, et al. “Oldhamianoside II Inhibits Prostate Cancer Progression via Regulation of EMT and the Wnt/Β‑catenin Signaling Pathway.” Oncology Letters, vol. 15, no. 6, June 2018, pp. 9457–63. EBSCOhost, https://doi.org/10.3892/ol.2018.8450.
APA
Li, K., Zhan, X., Sun, J., Wang, T., Dong, H., Jing, F., Li, D., Cao, Y., Liu, Y., Wang, L., & Li, S. (2018). Oldhamianoside II inhibits prostate cancer progression via regulation of EMT and the Wnt/β‑catenin signaling pathway. Oncology Letters, 15(6), 9457–9463. https://doi.org/10.3892/ol.2018.8450
Chicago
Li, Kaizhi, Xuemei Zhan, Jingyong Sun, TianfENg Wang, Hongyan Dong, Fanbo Jing, Dongmei Li, et al. 2018. “Oldhamianoside II Inhibits Prostate Cancer Progression via Regulation of EMT and the Wnt/Β‑catenin Signaling Pathway.” Oncology Letters 15 (6): 9457–63. doi:10.3892/ol.2018.8450.